Short Interest in Edap Tms S.A. (NASDAQ:EDAP) Declines By 7.3%

Edap Tms S.A. (NASDAQ:EDAP) was the target of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 104,100 shares, a decrease of 7.3% from the March 15th total of 112,300 shares. Based on an average daily trading volume, of 41,200 shares, the short-interest ratio is presently 2.5 days.

Hedge Funds Weigh In On Edap Tms

A number of hedge funds have recently made changes to their positions in the business. State of Tennessee Treasury Department bought a new stake in Edap Tms during the 4th quarter worth about $38,000. New York State Common Retirement Fund boosted its stake in shares of Edap Tms by 391.4% in the 1st quarter. New York State Common Retirement Fund now owns 4,629 shares of the medical equipment provider’s stock valued at $51,000 after purchasing an additional 3,687 shares during the last quarter. Milestone Investment Advisors LLC bought a new position in shares of Edap Tms in the 1st quarter valued at about $62,000. Russell Investments Group Ltd. boosted its stake in shares of Edap Tms by 202.2% in the 1st quarter. Russell Investments Group Ltd. now owns 5,784 shares of the medical equipment provider’s stock valued at $63,000 after purchasing an additional 3,870 shares during the last quarter. Finally, BNP Paribas Arbitrage SNC bought a new position in shares of Edap Tms in the 3rd quarter valued at about $54,000. Institutional investors and hedge funds own 62.74% of the company’s stock.

Edap Tms Price Performance

Shares of EDAP stock traded down $0.12 during mid-day trading on Tuesday, reaching $7.31. The company’s stock had a trading volume of 23,987 shares, compared to its average volume of 39,959. Edap Tms has a 1-year low of $3.60 and a 1-year high of $12.23. The company has a market cap of $271.20 million, a P/E ratio of -11.59 and a beta of 0.74. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.30 and a current ratio of 2.84. The firm’s 50-day moving average is $7.05 and its two-hundred day moving average is $6.25.

Wall Street Analysts Forecast Growth

Several research firms recently commented on EDAP. StockNews.com upgraded shares of Edap Tms from a “sell” rating to a “hold” rating in a research note on Thursday, April 11th. HC Wainwright upped their target price on shares of Edap Tms from $16.00 to $19.00 and gave the company a “buy” rating in a research note on Monday, April 1st.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.